Lloyds Banking Group Plc American Depositary Shares vs Medpace Holdings Inc — how do they compare? Lloyds Banking Group Plc American Depositary Shares trades at $5.39 (market cap $76.34B), while Medpace Holdings Inc trades at $615.17 (market cap $16.82B). The key difference: Lloyds Banking Group Plc American Depositary Shares is far larger — about 4.5× Medpace Holdings Inc's market cap, and Lloyds Banking Group Plc American Depositary Shares pays a 4.05% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lloyds Banking Group Plc American Depositary Shares for 0 Days and Medpace Holdings Inc for 14 Days on average.
| LYG | MEDP | |
|---|---|---|
Market Cap | $76.34B | $16.82B |
Volume | 16,671,733 | 223,093 |
Sector | Financials | Health |
52-Week High | $6.28 | $630.19 |
52-Week Low | $4.42 | $393.42 |
Typical Hold Time | 0 Days | 14 Days |
Enterprise Value | $99.66B | $16.44B |
Dividend Yield | 4.05% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MEDP trades at $604.25, up 0.22% today, with a neutral technical signal and strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected on October 21, 2026. Revenue grew to $2.53 billion in 2025, with a net income margin of 17.67% and robust ROE of 162.15%. Analyst consensus is a $620.44 price target, though institutional sentiment is mixed with recent CEO share sales.
Outlook remains positive given earnings momentum and projected 2026 revenue growth to $2.8 billion. Key risks include high valuation multiples and insider selling. The stock offers upside to consensus target but requires monitoring of Q3 earnings and competitive pressures in medical services.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Lloyds Banking Group provides retail, commercial, and insurance services in the United Kingdom. Its banking brands include Lloyds Bank, Halifax, and Bank of Scotland.
Read more on LYG →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →